EntityRisk webcast series
Featuring: Darius Lakdawalla PhD and Neal Masia PhD
Episode 1: 2023 – How to determine commercial value in a downturn
January 2023
How can you predict how payers around the world will value new therapies when caution remains the dominant theme of 2023? Darius Lakdawalla and EntityRisk CEO Neal Masia answer that question in the webcast below. They also discuss the news from JPM 2023 and review formulas for success in a prolonged downturn.